New Starting Point, New Journey | Hemos Bioscience R&D Center Officially Moves into the Chongqing Biomanufacturing Industry Pilot-Scale Platform

The head of the R&D center and team members, drawing on their practical experience, shared their expectations for the new platform and environment. They unanimously emphasized that the pilot‑scale platform not only offers superior experimental conditions and a comprehensive validation setup but also represents a critical opportunity to advance R&D from laboratory‑scale trials to industrial‑scale production. Looking ahead, they will leverage the new facilities, adopt a fresh mindset, focus intently on key technological targets, accelerate project development, and translate more scientific breakthroughs into tangible manufacturing processes.

Company leaders and heads of all departments also offered their expectations during the discussion, unanimously agreeing that the R&D Center is the core engine of the company’s technological innovation. Moving forward, each department will fully coordinate and provide robust support, pooling resources across quality, production, marketing, and other functions to ensure the efficient advancement of R&D projects and jointly drive the company toward sustained breakthroughs in the field of biomanufacturing.

The pilot-scale platform brings together industrial resources, technical services, and the advantages of technology transfer, serving as a critical bridge between fundamental research and industrial application. By locating its R&D center here, the organization can leverage the platform’s resources to enhance pilot-scale scale-up and process optimization capabilities, while also integrating more deeply into the regional bio-manufacturing ecosystem and expanding opportunities for industry–university–research collaboration.

From the laboratory to the pilot-scale platform, this is not merely a change of location; it represents a leap in R&D capabilities. In the future, Hemos Bioscience will leverage its pilot-scale platform as a strategic pivot to accelerate breakthroughs in key technologies and their industrial application within the biomanufacturing sector. By continuously strengthening its core technologies and expediting the commercialization of innovative results, Hemos Bio will contribute even more significantly to the development of the biomanufacturing industry with stronger R&D capabilities and more efficient industrial collaboration.

A new platform, a new journey. Hemos Bioscience R&D Center sets sail!